Page 1655 - Clinical Small Animal Internal Medicine
P. 1655
Index 1593
anthrax 973 head trauma 749–750 orbital and optic nerve
VetBooks.ir central diabetes insipidus (CDI) 65, myelopathy 820 plasma cell disorders 1245–1246
meningoencephalitis and
bartonellosis 924
tumors 1269
rabies 892, 896
meningomyelitis 795, 797–799
soft tissue sarcomas 1336–1337
68, 1071 protozoal and protozoa‐like urinary tract tumors 1308, 1310
central nervous system (CNS) infections 1004–1006 chest compressions 366–367
acute poisoning 437, 442 seizures and movement chest wall 294–295
antifungal therapy 1051 disorders 771 cheyletiellosis 1456–1457
forebrain disorders 781–784 cerebrovascular accidents (CVA) diagnosis 1457
fungal infections 986, 989–990, 785–787 etiology/pathophysiology
992–993 Certified Applied Animal Behaviorists 1456–1457, 1456
head trauma 748–758, 750, (CAAB) 1576 history and clinical signs 1457, 1457
751–752, 752, 754 ceruminous gland adenoma 1474 treatment and prognosis 1457
meningoencephalitis and CH see cutaneous histiocytosis CHF see congestive heart failure
meningomyelitis 795–801 Chagas disease 1007–1008 CHI see congenital hyperinsulinism
myelopathy 816, 821 CHD see canine hip dysplasia; Chiari‐like malformation 1488
neurologic assessment 732 congenital heart disease chigger mites see trombiculosis
nonhemotropic Mycoplasma, chemical burns 544 cholangitis 669, 669, 721–722
Ureaplasma, and L‐form chemical load 382–383, 388–389 cholangitis‐cholangiohepatitis
bacteria 933 chemoembolization 1202 see feline inflammatory liver
rabies 891 chemoradiotherapy 541 disease
septic shock 424 chemoreceptors 404 cholecentesis 724–725
spinal cord injury 741–748, chemotherapy cholecystitis 670, 670
742–745, 745–746, 747 airway and lung cancers 1278, 1280 choleliths 721, 724
spotted fever and typhus group approach to the cancer cholestasis 641–642
Rickettsia 938–939 patient 1202, 1203 cholesteatoma 791
vestibular disease 789–790, biology of cancer and cancer cholesterol 83, 650–651
792–794 genetics 1206, 1209 chondrocytes 1510–1511
central nervous system (CNS) bone and joint tumors 1331 chondrosarcoma (CSA) 1327, 1332
tumors 1247–1252 cardiac neoplasia 1273–1274 choroidal melanocytoma/
diagnosis 1248–1249, 1249 central nervous system melanoma 1264–1265
etiology/epidemiology/ tumors 1252 choroid plexus papillomas 779
signalment 1247–1248 esophageal and stomach chronic degenerative valvular disease
history and clinical signs 1248 cancers 1285 (CDVD) 178
lymphomas 1237–1238 exocrine pancreatic cancer 1294 chronic enteropathies (CE) 627–637
treatment and prognosis gynecologic cancers 1318–1320 adjunctive therapy 637
1249–1252, 1251 hemangiosarcoma 1342, antibiotic‐responsive diarrhea 627,
central pontine demyelination 1343–1344 629, 636
(CPD) 1073 hepatobiliary tumors 1306 antiinflammatory and
central venous oxygen intestinal cancers 1290–1291 immunosuppressive
saturation 411–412 intraocular tumors 1267 therapy 636
central venous pressure (CVP) lymphoid leukemias 1225 calprotectin and S100A12 634
327, 364 lymphomas 1233–1235, 1234, canine pancreatic lipase 633
cephalosporins 1045 1238–1239, 1238 classification 627
cerebellar ataxia 732 male reproductive system C‐reactive protein 633
cerebellar‐related tremors 770 tumors 1312, 1315 diagnostic imaging 635
cerebral blood flow (CBF) 748 mammary cancer 1322–1324 diagnostic work‐up 629–630,
cerebral edema 749 mast cell tumors 1363–1364, 1363 630, 631
cerebral perfusion pressure melanoma 1349 diet and nutrition 635–636
(CPP) 748, 755 myelodysplastic syndromes 1230 epidemiology 629
cerebrospinal fluid (CSF) myeloid neoplasia 1227 etiopathogenesis 627–629, 628
central nervous system nasal tumors 1258 fecal alpha‐1‐proteinase
tumors 1248 nonmelanoma skin cancers inhibitor 633
forebrain disorders 775, 782–784, 1356–1357 food‐responsive diarrhea 627–629,
787–788 oral tumors 1255–1256 634–637
